DOCSLIB.ORG

Supplemetary Table 2. List of Genes Down-Regulated in LPAR6 Knocked Down Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplemetary Table 2. List of Genes Down-Regulated in LPAR6 Knocked Down Cells Supplemetary Table 2. List of genes down-regulated in LPAR6 knocked down cells g# initial alias c# converted alias name description namespace 1 NM_002317.5 1.1 ENSG00000113083 LOX lysyl oxidase [Source:HGNC Symbol;Acc:6664] REFSEQ_MRNA 2 NM_006183.4 2.1 ENSG00000133636 NTS neurotensin [Source:HGNC Symbol;Acc:8038] REFSEQ_MRNA 3 NM_005213.3 3.1 ENSG00000121552 CSTA cystatin A (stefin A) [Source:HGNC Symbol;Acc:2481] REFSEQ_MRNA 4 NM_007231.3 4.1 ENSG00000087916 SLC6A14 solute carrier family 6 (amino acid transporter), member 14 [Source:HGNC Symbol;Acc:11047] REFSEQ_MRNA 5 NM_001873.2 5.1 ENSG00000109472 CPE carboxypeptidase E [Source:HGNC Symbol;Acc:2303] REFSEQ_MRNA 6 NM_019856.1 6.1 ENSG00000101605 MYOM1 myomesin 1, 185kDa [Source:HGNC Symbol;Acc:7613] REFSEQ_MRNA 7 NM_032590.4 7.1 ENSG00000089094 KDM2B lysine (K)-specific demethylase 2B [Source:HGNC Symbol;Acc:13610] REFSEQ_MRNA 8 NM_001901.2 8.1 ENSG00000118523 CTGF connective tissue growth factor [Source:HGNC Symbol;Acc:2500] REFSEQ_MRNA 9 NM_007183.2 9.1 ENSG00000184363 PKP3 plakophilin 3 [Source:HGNC Symbol;Acc:9025] REFSEQ_MRNA 10 NM_182965.2 10.1 ENSG00000176170 SPHK1 sphingosine kinase 1 [Source:HGNC Symbol;Acc:11240] REFSEQ_MRNA 11 NM_152423.4 11.1 ENSG00000157502 MUM1L1 melanoma associated antigen (mutated) 1-like 1 [Source:HGNC Symbol;Acc:26583] REFSEQ_MRNA 12 NM_002923.3 12.1 ENSG00000116741 RGS2 regulator of G-protein signaling 2, 24kDa [Source:HGNC Symbol;Acc:9998] REFSEQ_MRNA 13 NR_003038.2 13.1 N/A N/A N/A N/A 14 NM_080862.1 14.1 ENSG00000175093 SPSB4 splA/ryanodine receptor domain and SOCS box containing 4 [Source:HGNC Symbol;Acc:30630] REFSEQ_MRNA 15 NM_001649.2 15.1 ENSG00000146950 SHROOM2 shroom family member 2 [Source:HGNC Symbol;Acc:630] REFSEQ_MRNA 16 NM_014141.5 16.1 ENSG00000174469 CNTNAP2 contactin associated protein-like 2 [Source:HGNC Symbol;Acc:13830] REFSEQ_MRNA 17 NR_001568.1 17.1 ENSG00000236824 BCYRN1 brain cytoplasmic RNA 1 (non-protein coding) [Source:HGNC Symbol;Acc:1022] REFSEQ_NCRNA 18 NM_024911.6 18.1 ENSG00000116729 WLS wntless homolog (Drosophila) [Source:HGNC Symbol;Acc:30238] REFSEQ_MRNA 19 NM_002630.3 19.1 ENSG00000096088 PGC progastricsin (pepsinogen C) [Source:HGNC Symbol;Acc:8890] REFSEQ_MRNA 20 NM_020453.3 20.1 ENSG00000145246 ATP10D ATPase, class V, type 10D [Source:HGNC Symbol;Acc:13549] REFSEQ_MRNA 21 NR_033979.1 21.1 ENSG00000224189 AC009336.23 N/A REFSEQ_NCRNA 22 NM_003897.3 22.1 ENSG00000137331 IER3 immediate early response 3 [Source:HGNC Symbol;Acc:5392] REFSEQ_MRNA 23 NM_025069.1 23.1 ENSG00000183779 ZNF703 zinc finger protein 703 [Source:HGNC Symbol;Acc:25883] REFSEQ_MRNA 24 NM_002203.3 24.1 ENSG00000164171 ITGA2 integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) [Source:HGNC Symbol;Acc:6137] REFSEQ_MRNA thiosulfate sulfurtransferase (rhodanese)-like domain containing 1 [Source:HGNC 25 NM_001113205.1 25.1 ENSG00000215845 TSTD1 REFSEQ_MRNA Symbol;Acc:35410] 26 NM_013233.2 26.1 ENSG00000198648 STK39 serine threonine kinase 39 [Source:HGNC Symbol;Acc:17717] REFSEQ_MRNA 27 NR_034138.1 27.1 ENSG00000250846 RP11-807H7.1 N/A REFSEQ_NCRNA 28 NM_001935.3 28.1 ENSG00000197635 DPP4 dipeptidyl-peptidase 4 [Source:HGNC Symbol;Acc:3009] REFSEQ_MRNA 29 NG_008080.1 29.1 N/A N/A N/A N/A 30 NM_032608.5 30.1 ENSG00000133454 MYO18B myosin XVIIIB [Source:HGNC Symbol;Acc:18150] REFSEQ_MRNA 31 NM_080759.4 31.1 ENSG00000165659 DACH1 dachshund homolog 1 (Drosophila) [Source:HGNC Symbol;Acc:2663] REFSEQ_MRNA 32 NG_012743.1 32.1 N/A N/A N/A N/A 33 NM_013437.4 33.1 ENSG00000147650 LRP12 low density lipoprotein receptor-related protein 12 [Source:HGNC Symbol;Acc:31708] REFSEQ_MRNA solute carrier family 1 (glial high affinity glutamate transporter), member 3 [Source:HGNC 34 NM_004172.4 34.1 ENSG00000079215 SLC1A3 REFSEQ_MRNA Symbol;Acc:10941] 35 NM_001801.2 35.1 ENSG00000129596 CDO1 cysteine dioxygenase, type I [Source:HGNC Symbol;Acc:1795] REFSEQ_MRNA glycerophosphodiester phosphodiesterase domain containing 5 [Source:HGNC 36 NM_030792.6 36.1 ENSG00000158555 GDPD5 REFSEQ_MRNA Symbol;Acc:28804] 37 NM_001039348.2 37.1 ENSG00000115380 EFEMP1 EGF containing fibulin-like extracellular matrix protein 1 [Source:HGNC Symbol;Acc:3218] REFSEQ_MRNA 38 NM_001191013.1 38.1 ENSG00000065621 GSTO2 glutathione S-transferase omega 2 [Source:HGNC Symbol;Acc:23064] REFSEQ_MRNA 39 NM_153620.2 39.1 ENSG00000105991 HOXA1 homeobox A1 [Source:HGNC Symbol;Acc:5099] REFSEQ_MRNA tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) [Source:HGNC 40 NM_001032281.2 40.1 ENSG00000003436 TFPI REFSEQ_MRNA Symbol;Acc:11760] 41 NM_002779.3 41.1 ENSG00000059915 PSD pleckstrin and Sec7 domain containing [Source:HGNC Symbol;Acc:9507] REFSEQ_MRNA 42 NR_039989.1 42.1 N/A N/A N/A N/A 43 NM_001259.6 43.1 ENSG00000105810 CDK6 cyclin-dependent kinase 6 [Source:HGNC Symbol;Acc:1777] REFSEQ_MRNA 44 NM_019032.4 44.1 ENSG00000143382 ADAMTSL4 ADAMTS-like 4 [Source:HGNC Symbol;Acc:19706] REFSEQ_MRNA 45 NM_002589.2 45.1 ENSG00000169851 PCDH7 protocadherin 7 [Source:HGNC Symbol;Acc:8659] REFSEQ_MRNA 46 NM_005627.3 46.1 ENSG00000118515 SGK1 serum/glucocorticoid regulated kinase 1 [Source:HGNC Symbol;Acc:10810] REFSEQ_MRNA 47 NM_000607.2 47.1 ENSG00000229314 ORM1 orosomucoid 1 [Source:HGNC Symbol;Acc:8498] REFSEQ_MRNA 48 NG_012842.1 48.1 N/A N/A N/A N/A 49 NM_005647.3 49.1 ENSG00000101849 TBL1X transducin (beta)-like 1, Y-linked [Source:HGNC Symbol;Acc:18502] REFSEQ_MRNA 49 NM_005647.3 49.1 ENSG00000101849 TBL1X transducin (beta)-like 1X-linked [Source:HGNC Symbol;Acc:11585] REFSEQ_MRNA 50 NM_024721.4 50.1 ENSG00000091656 ZFHX4 zinc finger homeobox 4 [Source:HGNC Symbol;Acc:30939] REFSEQ_MRNA 51 NM_004439.5 51.1 ENSG00000145242 EPHA5 EPH receptor A5 [Source:HGNC Symbol;Acc:3389] REFSEQ_MRNA 52 NM_001174060.1 52.1 ENSG00000144645 OSBPL10 oxysterol binding protein-like 10 [Source:HGNC Symbol;Acc:16395] REFSEQ_MRNA 53 NM_016020.3 53.1 ENSG00000029639 TFB1M transcription factor B1, mitochondrial [Source:HGNC Symbol;Acc:17037] REFSEQ_MRNA 54 NM_005767.5 54.1 ENSG00000139679 LPAR6 lysophosphatidic acid receptor 6 [Source:HGNC Symbol;Acc:15520] REFSEQ_MRNA sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B 55 NM_032108.3 55.1 ENSG00000167680 SEMA6B REFSEQ_MRNA [Source:HGNC Symbol;Acc:10739] 56 NM_024420.2 56.1 ENSG00000116711 PLA2G4A phospholipase A2, group IVA (cytosolic, calcium-dependent) [Source:HGNC Symbol;Acc:9035] REFSEQ_MRNA 57 NR_027404.1 57.1 ENSG00000197568 HHLA3 HERV-H LTR-associating 3 [Source:HGNC Symbol;Acc:4906] REFSEQ_NCRNA 58 NM_030661.4 58.1 ENSG00000105997 HOXA3 homeobox A3 [Source:HGNC Symbol;Acc:5104] REFSEQ_MRNA 59 NM_170672.2 59.1 ENSG00000152689 RASGRP3 RAS guanyl releasing protein 3 (calcium and DAG-regulated) [Source:HGNC Symbol;Acc:14545] REFSEQ_MRNA 60 NM_032040.4 60.1 N/A N/A N/A N/A CD55 molecule, decay accelerating factor for complement (Cromer blood group) [Source:HGNC 61 NM_000574.3 61.1 ENSG00000196352 CD55 REFSEQ_MRNA Symbol;Acc:2665] 62 NM_024726.3 62.1 ENSG00000132321 IQCA1 IQ motif containing with AAA domain 1 [Source:HGNC Symbol;Acc:26195] REFSEQ_MRNA 63 NM_004385.4 63.1 ENSG00000038427 VCAN versican [Source:HGNC Symbol;Acc:2464] REFSEQ_MRNA 64 NM_016524.2 64.1 ENSG00000103528 SYT17 synaptotagmin XVII [Source:HGNC Symbol;Acc:24119] REFSEQ_MRNA 65 NM_138323.1 65.1 ENSG00000140479 PCSK6 proprotein convertase subtilisin/kexin type 6 [Source:HGNC Symbol;Acc:8569] REFSEQ_MRNA 66 NM_138325.2 66.1 ENSG00000140479 PCSK6 proprotein convertase subtilisin/kexin type 6 [Source:HGNC Symbol;Acc:8569] REFSEQ_MRNA 67 NM_002994.3 67.1 ENSG00000163735 CXCL5 chemokine (C-X-C motif) ligand 5 [Source:HGNC Symbol;Acc:10642] REFSEQ_MRNA 68 NM_001040022.1 68.1 ENSG00000198053 SIRPA signal-regulatory protein alpha [Source:HGNC Symbol;Acc:9662] REFSEQ_MRNA 69 NM_000071.2 69.1 ENSG00000160200 CBS cystathionine-beta-synthase [Source:HGNC Symbol;Acc:1550] REFSEQ_MRNA 70 NM_012454.3 70.1 ENSG00000146426 TIAM2 T-cell lymphoma invasion and metastasis 2 [Source:HGNC Symbol;Acc:11806] REFSEQ_MRNA 71 NM_002126.4 71.1 ENSG00000108924 HLF hepatic leukemia factor [Source:HGNC Symbol;Acc:4977] REFSEQ_MRNA 72 NM_003680.3 72.1 ENSG00000134684 YARS tyrosyl-tRNA synthetase [Source:HGNC Symbol;Acc:12840] REFSEQ_MRNA 73 NM_001025266.1 73.1 ENSG00000187068 C3ORF70 chromosome 3 open reading frame 70 [Source:HGNC Symbol;Acc:33731] REFSEQ_MRNA HOXA transcript antisense RNA, myeloid-specific 1 (non-protein coding) [Source:HGNC 74 NR_038366.1 74.1 ENSG00000233429 HOTAIRM1 REFSEQ_NCRNA Symbol;Acc:37117] 75 NM_002429.4 75.1 ENSG00000123342 MMP19 matrix metallopeptidase 19 [Source:HGNC Symbol;Acc:7165] REFSEQ_MRNA 76 NM_000607.2 76.1 ENSG00000229314 ORM1 orosomucoid 1 [Source:HGNC Symbol;Acc:8498] REFSEQ_MRNA 77 NM_016548.3 77.1 ENSG00000135052 GOLM1 golgi membrane protein 1 [Source:HGNC Symbol;Acc:15451] REFSEQ_MRNA 78 NM_001161473.1 78.1 ENSG00000006534 ALDH3B1 aldehyde dehydrogenase 3 family, member B1 [Source:HGNC Symbol;Acc:410] REFSEQ_MRNA 79 NM_177551.3 79.1 ENSG00000182782 HCAR2 hydroxycarboxylic acid receptor 2 [Source:HGNC Symbol;Acc:24827] REFSEQ_MRNA 80 NM_001256310.1 80.1 N/A N/A N/A N/A 81 NM_002501.2 81.1 ENSG00000008441 NFIX nuclear factor I/X (CCAAT-binding transcription factor) [Source:HGNC Symbol;Acc:7788] REFSEQ_MRNA 82 NM_000442.4 82.1 N/A N/A N/A N/A 83 NM_006018.2 83.1 ENSG00000255398 HCAR3 hydroxycarboxylic acid receptor 3 [Source:HGNC Symbol;Acc:16824] REFSEQ_MRNA 84 NM_001040092.2 84.1 N/A N/A N/A N/A 85 NR_015396.1 85.1 ENSG00000214725 AC120114.1 N/A REFSEQ_NCRNA 86 NM_015944.3 86.1 ENSG00000162066 AMDHD2 amidohydrolase domain
Load more

Recommended publications
  • Supplementary Data
    Figure 2S 4 7 A - C 080125 CSCs 080418 CSCs - + IFN-a 48 h + IFN-a 48 h + IFN-a 72 h 6 + IFN-a 72 h 3 5 MRFI 4 2 3 2 1 1 0 0 MHC I MHC II MICA MICB ULBP-1 ULBP-2 ULBP-3 ULBP-4 MHC I MHC II MICA MICB ULBP-1 ULBP-2 ULBP-3 ULBP-4 7 B 13 080125 FBS - D 080418 FBS - + IFN-a 48 h 12 + IFN-a 48 h + IFN-a 72 h + IFN-a 72 h 6 080125 FBS 11 10 5 9 8 4 7 6 3 MRFI 5 4 2 3 2 1 1 0 0 MHC I MHC II MICA MICB ULBP-1 ULBP-2 ULBP-3 ULBP-4 MHC I MHC II MICA MICB ULBP-1 ULBP-2 ULBP-3 ULBP-4 Molecule Molecule FIGURE 4S FIGURE 5S Panel A Panel B FIGURE 6S A B C D Supplemental Results Table 1S. Modulation by IFN-α of APM in GBM CSC and FBS tumor cell lines. Molecule * Cell line IFN-α‡ HLA β2-m# HLA LMP TAP1 TAP2 class II A A HC§ 2 7 10 080125 CSCs - 1∞ (1) 3 (65) 2 (91) 1 (2) 6 (47) 2 (61) 1 (3) 1 (2) 1 (3) + 2 (81) 11 (80) 13 (99) 1 (3) 8 (88) 4 (91) 1 (2) 1 (3) 2 (68) 080125 FBS - 2 (81) 4 (63) 4 (83) 1 (3) 6 (80) 3 (67) 2 (86) 1 (3) 2 (75) + 2 (99) 14 (90) 7 (97) 5 (75) 7 (100) 6 (98) 2 (90) 1 (4) 3 (87) 080418 CSCs - 2 (51) 1 (1) 1 (3) 2 (47) 2 (83) 2 (54) 1 (4) 1 (2) 1 (3) + 2 (81) 3 (76) 5 (75) 2 (50) 2 (83) 3 (71) 1 (3) 2 (87) 1 (2) 080418 FBS - 1 (3) 3 (70) 2 (88) 1 (4) 3 (87) 2 (76) 1 (3) 1 (3) 1 (2) + 2 (78) 7 (98) 5 (99) 2 (94) 5 (100) 3 (100) 1 (4) 2 (100) 1 (2) 070104 CSCs - 1 (2) 1 (3) 1 (3) 2 (78) 1 (3) 1 (2) 1 (3) 1 (3) 1 (2) + 2 (98) 8 (100) 10 (88) 4 (89) 3 (98) 3 (94) 1 (4) 2 (86) 2 (79) * expression of APM molecules was evaluated by intracellular staining and cytofluorimetric analysis; ‡ cells were treatead or not (+/-) for 72 h with 1000 IU/ml of IFN-α; # β-2 microglobulin; § β-2 microglobulin-free HLA-A heavy chain; ∞ values are indicated as ratio between the mean of fluorescence intensity of cells stained with the selected mAb and that of the negative control; bold values indicate significant MRFI (≥ 2).
    [Show full text]
  • Analysis of Gene Expression Data for Gene Ontology
    ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION A Thesis Presented to The Graduate Faculty of The University of Akron In Partial Fulfillment of the Requirements for the Degree Master of Science Robert Daniel Macholan May 2011 ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION Robert Daniel Macholan Thesis Approved: Accepted: _______________________________ _______________________________ Advisor Department Chair Dr. Zhong-Hui Duan Dr. Chien-Chung Chan _______________________________ _______________________________ Committee Member Dean of the College Dr. Chien-Chung Chan Dr. Chand K. Midha _______________________________ _______________________________ Committee Member Dean of the Graduate School Dr. Yingcai Xiao Dr. George R. Newkome _______________________________ Date ii ABSTRACT A tremendous increase in genomic data has encouraged biologists to turn to bioinformatics in order to assist in its interpretation and processing. One of the present challenges that need to be overcome in order to understand this data more completely is the development of a reliable method to accurately predict the function of a protein from its genomic information. This study focuses on developing an effective algorithm for protein function prediction. The algorithm is based on proteins that have similar expression patterns. The similarity of the expression data is determined using a novel measure, the slope matrix. The slope matrix introduces a normalized method for the comparison of expression levels throughout a proteome. The algorithm is tested using real microarray gene expression data. Their functions are characterized using gene ontology annotations. The results of the case study indicate the protein function prediction algorithm developed is comparable to the prediction algorithms that are based on the annotations of homologous proteins.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Related Malignant Phenotypes in the Nf1-Deficient MPNST
    Published OnlineFirst February 19, 2013; DOI: 10.1158/1541-7786.MCR-12-0593 Molecular Cancer Genomics Research RAS/MEK–Independent Gene Expression Reveals BMP2- Related Malignant Phenotypes in the Nf1-Deficient MPNST Daochun Sun1, Ramsi Haddad2,3, Janice M. Kraniak2, Steven D. Horne1, and Michael A. Tainsky1,2 Abstract Malignant peripheral nerve sheath tumor (MPNST) is a type of soft tissue sarcoma that occurs in carriers of germline mutations in Nf1 gene as well as sporadically. Neurofibromin, encoded by the Nf1 gene, functions as a GTPase-activating protein (GAP) whose mutation leads to activation of wt-RAS and mitogen-activated protein kinase (MAPK) signaling in neurofibromatosis type I (NF1) patients' tumors. However, therapeutic targeting of RAS and MAPK have had limited success in this disease. In this study, we modulated NRAS, mitogen-activated protein/extracellular signal–regulated kinase (MEK)1/2, and neurofibromin levels in MPNST cells and determined gene expression changes to evaluate the regulation of signaling pathways in MPNST cells. Gene expression changes due to neurofibromin modulation but independent of NRAS and MEK1/2 regulation in MPNST cells indicated bone morphogenetic protein 2 (Bmp2) signaling as a key pathway. The BMP2-SMAD1/5/8 pathway was activated in NF1-associated MPNST cells and inhibition of BMP2 signaling by LDN-193189 or short hairpin RNA (shRNA) to BMP2 decreased the motility and invasion of NF1-associated MPNST cells. The pathway-specific gene changes provide a greater understanding of the complex role of neurofibromin in MPNST pathology and novel targets for drug discovery. Mol Cancer Res; 11(6); 616–27.
    [Show full text]
  • The Direction of Cross Affects Obesity After Puberty in Male but Not Female
    Kärst et al. BMC Genomics (2015) 16:904 DOI 10.1186/s12864-015-2164-2 RESEARCH ARTICLE Open Access The direction of cross affects obesity after puberty in male but not female offspring Stefan Kärst1†, Danny Arends1†, Sebastian Heise1†, Jan Trost1, Marie-Laure Yaspo2, Vyacheslav Amstislavskiy2, Thomas Risch2, Hans Lehrach2 and Gudrun A. Brockmann1* Abstract Background: We investigated parent-of-origin and allele-specific expression effects on obesity and hepatic gene expression in reciprocal crosses between the Berlin Fat Mouse Inbred line (BFMI) and C57Bl/6NCrl (B6N). Results: We found that F1-males with a BFMI mother developed 1.8 times more fat mass on a high fat diet at 10 weeks than F1-males of a BFMI father. The phenotype was detectable from six weeks on and was preserved after cross-fostering. RNA-seq data of liver provided evidence for higher biosynthesis and elongation of fatty acids (p = 0.00635) in obese male offspring of a BFMI mother versus lean offspring of a BFMI father. Furthermore, fatty acid degradation (p = 0.00198) and the peroxisome pathway were impaired (p = 0.00094). The circadian rhythm was affected as well (p = 0.00087). Among the highest up-regulated protein coding genes in obese males were Acot4 (1.82 fold, p = 0.022), Cyp4a10 (1.35 fold, p = 0.026) and Cyp4a14 (1.32 fold, p = 0.012), which hydroxylize fatty acids and which are known to be increased in liver steatosis. Obese males showed lower expression of the genetically imprinted and paternally expressed 3 (Peg3) gene (0.31 fold, p = 0.046) and higher expression of the androgen receptor (Ar) gene (2.38 fold, p = 0.068).
    [Show full text]
  • Hypertension and Prolonged Vasoconstrictor Signaling in RGS2- Deficient Mice
    Amendment history: Addendum (April 2003) Hypertension and prolonged vasoconstrictor signaling in RGS2- deficient mice Scott P. Heximer, … , Robert P. Mecham, Kendall J. Blumer J Clin Invest. 2003;111(4):445-452. https://doi.org/10.1172/JCI15598. Article Cardiology Signaling by hormones and neurotransmitters that activate G protein–coupled receptors (GPCRs) maintains blood pressure within the normal range despite large changes in cardiac output that can occur within seconds. This implies that blood pressure regulation requires precise kinetic control of GPCR signaling. To test this hypothesis, we analyzed mice deficient in RGS2, a GTPase-activating protein that greatly accelerates the deactivation rate of heterotrimeric G proteins in vitro. Both rgs2+/– and rgs2–/– mice exhibited a strong hypertensive phenotype, renovascular abnormalities, persistent constriction of the resistance vasculature, and prolonged response of the vasculature to vasoconstrictors in vivo. Analysis of P2Y receptor–mediated Ca2+ signaling in vascular smooth muscle cells in vitro indicated that loss of RGS2 increased agonist potency and efficacy and slowed the kinetics of signal termination. These results establish that abnormally prolonged signaling by G protein–coupled vasoconstrictor receptors can contribute to the onset of hypertension, and they suggest that genetic defects affecting the function or expression of RGS2 may be novel risk factors for development of hypertension in humans. Find the latest version: https://jci.me/15598/pdf Hypertension and prolonged See the related Commentary beginning on page 441. vasoconstrictor signaling in RGS2-deficient mice Scott P. Heximer,1 Russell H. Knutsen,1 Xiaoguang Sun,1 Kevin M. Kaltenbronn,1 Man-Hee Rhee,1 Ning Peng,2 Antonio Oliveira-dos-Santos,3 Josef M.
    [Show full text]
  • A CRISPR-Cas9–Engineered Mouse Model for GPI-Anchor Deficiency Mirrors Human Phenotypes and Exhibits Hippocampal Synaptic Dysfunctions
    A CRISPR-Cas9–engineered mouse model for GPI-anchor deficiency mirrors human phenotypes and exhibits hippocampal synaptic dysfunctions Miguel Rodríguez de los Santosa,b,c,d, Marion Rivalane,f, Friederike S. Davidd,g, Alexander Stumpfh, Julika Pitschi,j, Despina Tsortouktzidisi, Laura Moreno Velasquezh, Anne Voigth, Karl Schillingk, Daniele Matteil, Melissa Longe,f, Guido Vogta,c, Alexej Knausd, Björn Fischer-Zirnsaka,c, Lars Wittlerm, Bernd Timmermannn, Peter N. Robinsono,p, Denise Horna, Stefan Mundlosa,c, Uwe Kornaka,c,q, Albert J. Beckeri, Dietmar Schmitzh, York Wintere,f, and Peter M. Krawitzd,1 aInstitute for Medical Genetics and Human Genetics, Charité–Universitätsmedizin Berlin, 13353 Berlin, Germany; bBerlin-Brandenburg School for Regenerative Therapies, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany; cResearch Group Development and Disease, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany; dInstitute for Genomic Statistics and Bioinformatics, University of Bonn, 53127 Bonn, Germany; eAnimal Outcome Core Facility of the NeuroCure Center, Charité–Universitätsmedizin Berlin, 10117 Berlin, Germany; fInstitute of Cognitive Neurobiology, Humboldt University, 10117 Berlin, Germany; gInstitute of Human Genetics, Faculty of Medicine, University Hospital Bonn, 53127 Bonn, Germany; hNeuroscience Research Center, Charité–Universitätsmedizin Berlin, 10117 Berlin, Germany; iSection for Translational Epilepsy Research, Department of Neuropathology, University Hospital Bonn, 53127 Bonn, Germany; jDepartment of Epileptology,
    [Show full text]
  • Transcriptomic Analysis of Native Versus Cultured Human and Mouse Dorsal Root Ganglia Focused on Pharmacological Targets Short
    bioRxiv preprint doi: https://doi.org/10.1101/766865; this version posted September 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Transcriptomic analysis of native versus cultured human and mouse dorsal root ganglia focused on pharmacological targets Short title: Comparative transcriptomics of acutely dissected versus cultured DRGs Andi Wangzhou1, Lisa A. McIlvried2, Candler Paige1, Paulino Barragan-Iglesias1, Carolyn A. Guzman1, Gregory Dussor1, Pradipta R. Ray1,#, Robert W. Gereau IV2, # and Theodore J. Price1, # 1The University of Texas at Dallas, School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, 800 W Campbell Rd. Richardson, TX, 75080, USA 2Washington University Pain Center and Department of Anesthesiology, Washington University School of Medicine # corresponding authors [email protected], [email protected] and [email protected] Funding: NIH grants T32DA007261 (LM); NS065926 and NS102161 (TJP); NS106953 and NS042595 (RWG). The authors declare no conflicts of interest Author Contributions Conceived of the Project: PRR, RWG IV and TJP Performed Experiments: AW, LAM, CP, PB-I Supervised Experiments: GD, RWG IV, TJP Analyzed Data: AW, LAM, CP, CAG, PRR Supervised Bioinformatics Analysis: PRR Drew Figures: AW, PRR Wrote and Edited Manuscript: AW, LAM, CP, GD, PRR, RWG IV, TJP All authors approved the final version of the manuscript. 1 bioRxiv preprint doi: https://doi.org/10.1101/766865; this version posted September 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Investigation of Candidate Genes and Mechanisms Underlying Obesity
    Prashanth et al. BMC Endocrine Disorders (2021) 21:80 https://doi.org/10.1186/s12902-021-00718-5 RESEARCH ARTICLE Open Access Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules G. Prashanth1 , Basavaraj Vastrad2 , Anandkumar Tengli3 , Chanabasayya Vastrad4* and Iranna Kotturshetti5 Abstract Background: Obesity associated type 2 diabetes mellitus is a metabolic disorder ; however, the etiology of obesity associated type 2 diabetes mellitus remains largely unknown. There is an urgent need to further broaden the understanding of the molecular mechanism associated in obesity associated type 2 diabetes mellitus. Methods: To screen the differentially expressed genes (DEGs) that might play essential roles in obesity associated type 2 diabetes mellitus, the publicly available expression profiling by high throughput sequencing data (GSE143319) was downloaded and screened for DEGs. Then, Gene Ontology (GO) and REACTOME pathway enrichment analysis were performed. The protein - protein interaction network, miRNA - target genes regulatory network and TF-target gene regulatory network were constructed and analyzed for identification of hub and target genes. The hub genes were validated by receiver operating characteristic (ROC) curve analysis and RT- PCR analysis. Finally, a molecular docking study was performed on over expressed proteins to predict the target small drug molecules. Results: A total of 820 DEGs were identified between
    [Show full text]
  • Celsr1-3 Cadherins in PCP and Brain Development
    CHAPTER SEVEN Celsr1–3 Cadherins in PCP and Brain Development Camille Boutin, André M. Goffinet1, Fadel Tissir1 Institute of Neuroscience, Developmental Neurobiology, Universite´ Catholique de Louvain, Brussels, Belgium 1Corresponding authors: Equal contribution. e-mail address: [email protected]; andre. [email protected] Contents 1. Celsr1–3 Expression Patterns 164 2. Celsr1: A Major Player in Vertebrate PCP 165 3. Celsr2 and 3 in Ciliogenesis 169 4. Celsr1–3 in Neuronal Migration 171 5. Celsr2 and Celsr3 in Brain Wiring 174 5.1 Motifs of Celsr important for their functions 176 References 179 Abstract Cadherin EGF LAG seven-pass G-type receptors 1, 2, and 3 (Celsr1–3) form a family of three atypical cadherins with multiple functions in epithelia and in the nervous system. During the past decade, evidence has accumulated for important and distinct roles of Celsr1–3 in planar cell polarity (PCP) and brain development and maintenance. Although the role of Celsr in PCP is conserved from flies to mammals, other functions may be more distantly related, with Celsr working only with one or a subset of the classical PCP partners. Here, we review the literature on Celsr in PCP and neural devel- opment, point to several remaining questions, and consider future challenges and possible research trends. Celsr1–3 genes encode atypical cadherins of more than 3000 amino acids ( Fig. 7.1). Their large ectodomain is composed of nine N-terminal cadherin repeats (typical cadherins have five repeats), six epidermal growth factor (EGF)-like domains, two laminin G repeats, one hormone receptor motif (HRM), and a G-protein-coupled receptor proteolytic site (GPS).
    [Show full text]
  • NICU Gene List Generator.Xlsx
    Neonatal Crisis Sequencing Panel Gene List Genes: A2ML1 - B3GLCT A2ML1 ADAMTS9 ALG1 ARHGEF15 AAAS ADAMTSL2 ALG11 ARHGEF9 AARS1 ADAR ALG12 ARID1A AARS2 ADARB1 ALG13 ARID1B ABAT ADCY6 ALG14 ARID2 ABCA12 ADD3 ALG2 ARL13B ABCA3 ADGRG1 ALG3 ARL6 ABCA4 ADGRV1 ALG6 ARMC9 ABCB11 ADK ALG8 ARPC1B ABCB4 ADNP ALG9 ARSA ABCC6 ADPRS ALK ARSL ABCC8 ADSL ALMS1 ARX ABCC9 AEBP1 ALOX12B ASAH1 ABCD1 AFF3 ALOXE3 ASCC1 ABCD3 AFF4 ALPK3 ASH1L ABCD4 AFG3L2 ALPL ASL ABHD5 AGA ALS2 ASNS ACAD8 AGK ALX3 ASPA ACAD9 AGL ALX4 ASPM ACADM AGPS AMELX ASS1 ACADS AGRN AMER1 ASXL1 ACADSB AGT AMH ASXL3 ACADVL AGTPBP1 AMHR2 ATAD1 ACAN AGTR1 AMN ATL1 ACAT1 AGXT AMPD2 ATM ACE AHCY AMT ATP1A1 ACO2 AHDC1 ANK1 ATP1A2 ACOX1 AHI1 ANK2 ATP1A3 ACP5 AIFM1 ANKH ATP2A1 ACSF3 AIMP1 ANKLE2 ATP5F1A ACTA1 AIMP2 ANKRD11 ATP5F1D ACTA2 AIRE ANKRD26 ATP5F1E ACTB AKAP9 ANTXR2 ATP6V0A2 ACTC1 AKR1D1 AP1S2 ATP6V1B1 ACTG1 AKT2 AP2S1 ATP7A ACTG2 AKT3 AP3B1 ATP8A2 ACTL6B ALAS2 AP3B2 ATP8B1 ACTN1 ALB AP4B1 ATPAF2 ACTN2 ALDH18A1 AP4M1 ATR ACTN4 ALDH1A3 AP4S1 ATRX ACVR1 ALDH3A2 APC AUH ACVRL1 ALDH4A1 APTX AVPR2 ACY1 ALDH5A1 AR B3GALNT2 ADA ALDH6A1 ARFGEF2 B3GALT6 ADAMTS13 ALDH7A1 ARG1 B3GAT3 ADAMTS2 ALDOB ARHGAP31 B3GLCT Updated: 03/15/2021; v.3.6 1 Neonatal Crisis Sequencing Panel Gene List Genes: B4GALT1 - COL11A2 B4GALT1 C1QBP CD3G CHKB B4GALT7 C3 CD40LG CHMP1A B4GAT1 CA2 CD59 CHRNA1 B9D1 CA5A CD70 CHRNB1 B9D2 CACNA1A CD96 CHRND BAAT CACNA1C CDAN1 CHRNE BBIP1 CACNA1D CDC42 CHRNG BBS1 CACNA1E CDH1 CHST14 BBS10 CACNA1F CDH2 CHST3 BBS12 CACNA1G CDK10 CHUK BBS2 CACNA2D2 CDK13 CILK1 BBS4 CACNB2 CDK5RAP2
    [Show full text]
  • Abnormal Protein Phosphorylation in Human Amyotrophic Lateral Sclerosis
    ABNORMAL PROTEIN PHOSPHORYLATION IN HUMAN AMYOTROPHIC LATERAL SCLEROSIS Jie Hong Hu B.Sc., Zhongshan (Sun Yat-sen) University, 1993 M.Sc., Zhongshan (Sun Yat-sen) University, 1996 THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY In the School of KINESIOLOGY O Jie Hong Hu, 2003 SIMON FRASER UNIVERSITY September, 2003 All rights reserved. This work may not be reproduced in whole or in part, by photocopy or other means, without permission of the author. APPROVAL NAME: Jie Hong Hu DEGREE: Doctor of Philosophy TITLE OF THESIS: Abnormal protein phosphorylation in human amyotrophic lateral sclerosis (ALS) EXAMINING COMMITTEE: Chair: Dr. Parveen Bawa Professor Dr. Charles krieger Senior Supervisor Professor, School of Kinesiology BimeUraser University Dr. Wade Parkhouse Supervisor Professor, School of Kinesiology Simon Fraser University - Dr. Nick Harden Internal Examiner Assistant Professor, Department Molecular Biology and Biochemstry Simon Fraser University ~r.6rDurham External Examiner Professor, Department Neurology/Neurosurgery McGill University Date Approved: 16"' September 2003 PARTIAL COPYRIGHT LICENCE I hereby grant to Simon Fraser University the right to lend my thesis, project or extended essay (the title of which is shown below) to users of the Simon Fraser University Library, and to make partial or single copies only for such users or in response to a request from the library of any other university, or other educational institution, on its own behalf or for one of its users. I further agree that permission for multiple copying of this work for scholarly purposes may be granted by me or the Dean of Graduate Studies. It is understood that copying or publication of this work for financial gain shall not be allowed without my written permission.
    [Show full text]